Figure 4From: FGFR1 is amplified during the progression of in situto invasive breast carcinomaDisease-free survival according to FGFR1 amplification status. (A) Patients with FGFR1 amplified invasive breast cancer have significantly poorer disease-free survival than other patients. This finding applies to the hormone receptor (HR)-positive group (B) but not to the HR-negative group (C).Back to article page